Epitel

Blood test lab illustration
Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances
By Trevor Dermody | 03:45 pm | April 25, 2024
Epitel received 510(k) clearance for two remote monitoring offerings and Curio Digital Therapeutics received clearance for its postpartum prescription digital therapeutic.
Person at a desk looking at a computer
Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide
By Jessica Hagen | 04:48 pm | September 26, 2022
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
Healthcare professionals examining computer screen.
Ceribell raises $50M for seizure monitoring and detection technology
By Jessica Hagen | 01:50 pm | September 22, 2022
The company will use the funding to support the commercial expansion of its product.  
A person pulling back their hair to place the sensor
Epitel raises $12.5M for wearable seizure detection system
By Emily Olsen | 12:27 pm | February 16, 2022
The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.